{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T18:56:28Z","timestamp":1774032988783,"version":"3.50.1"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T00:00:00Z","timestamp":1540944000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0206386","type":"journal-article","created":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T17:49:55Z","timestamp":1541008195000},"page":"e0206386","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Correlation between image characteristics and pathologic findings in non small cell lung cancer patients after anatomic resection"],"prefix":"10.1371","volume":"13","author":[{"given":"Jui-Ying","family":"Fu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yung-Liang","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzu-Yen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Feng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Hen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Ju","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Cheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3838-6717","authenticated-orcid":true,"given":"Ching-Yang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,10,31]]},"reference":[{"issue":"5","key":"ref1","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"J Ferlay","year":"2015","journal-title":"Int J Cancer"},{"issue":"5","key":"ref2","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.aogh.2014.09.012","article-title":"A diversity of cancer incidence and mortality in West Asian populations","volume":"80","author":"G Roshandel","year":"2014","journal-title":"Ann Glob Health"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/annonc\/mdl498","article-title":"Estimates of the cancer incidence and mortality in Europe in 2006","volume":"18","author":"J Ferlay","year":"2007","journal-title":"Ann Oncol"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1158\/1055-9965.EPI-15-0578","article-title":"Global Cancer Incidence and Mortality Rates and Trends\u2014An Update","volume":"25","author":"LA Torre","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"45","key":"ref5","doi-asserted-by":"crossref","first-page":"e2013","DOI":"10.1097\/MD.0000000000002013","article-title":"Survival Prediction Model Using Clinico-Pathologic Characteristics for Nonsmall Cell Lung Cancer Patients After Curative Resection","volume":"94","author":"CY Wu","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"ref6","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/annonc\/mdn048","article-title":"Src as a potential therapeutic target in non-small-cell lung cancer","volume":"19","author":"G Giaccone","year":"2008","journal-title":"Ann Oncol"},{"key":"ref7"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1378\/chest.08-0978","article-title":"The new lung cancer staging system","volume":"136","author":"FC Detterbeck","year":"2009","journal-title":"Chest"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.chest.2016.10.010","article-title":"The Eighth Edition Lung Cancer Stage Classification","volume":"151","author":"FC Detterbeck","year":"2017","journal-title":"Chest"},{"issue":"10","key":"ref10","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJMoa0810699","article-title":"Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma","volume":"361","author":"TS Mok","year":"2009","journal-title":"N Engl J Med"},{"issue":"8","key":"ref11","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S1470-2045(11)70184-X","article-title":"Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study","volume":"12","author":"C Zhou","year":"2011","journal-title":"Lancet Oncol"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S1470-2045(12)70087-6","article-title":"Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b\/3 randomised trial","volume":"13","author":"VA Miller","year":"2012","journal-title":"Lancet Oncol"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S1470-2045(12)70086-4","article-title":"Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): a phase 2 trial","volume":"13","author":"JC Yang","year":"2012","journal-title":"Lancet Oncol"},{"issue":"27","key":"ref14","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1200\/JCO.2012.45.0981","article-title":"LUX-Lung 4: a phase II trial of afatinib in patients with advanced non-small-cell lung cancer who progressed during prior treatment with erlotinib, gefitinib, or both","volume":"31","author":"N Katakami","year":"2013","journal-title":"J Clin Oncol"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1470-2045(13)70604-1","article-title":"Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial","volume":"15","author":"YL Wu","year":"2014","journal-title":"Lancet Oncol"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1470-2045(14)71173-8","article-title":"Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials","volume":"16","author":"JC Yang","year":"2015","journal-title":"Lancet Oncol"},{"issue":"8","key":"ref17","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S1470-2045(15)00006-6","article-title":"Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial","volume":"16","author":"JC Soria","year":"2015","journal-title":"Lancet Oncol"},{"issue":"19","key":"ref18","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","article-title":"Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer","volume":"375","author":"M Reck","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1148\/radiol.10091808","article-title":"The National Lung Screening Trial: overview and study design","volume":"258","author":"DR Aberle","year":"2011","journal-title":"Radiology"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa1102873","article-title":"Reduced lung-cancer mortality with low-dose computed tomographic screening","volume":"365","author":"DR Aberle","year":"2011","journal-title":"N Engl J Med"},{"issue":"14","key":"ref21","first-page":"3212","article-title":"Characteristic analysis of pulmonary ground-glass lesions with the help of 64-slice CT technology","volume":"21","author":"YG Lv","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"10","key":"ref22","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.ejrad.2016.07.012","article-title":"Thin-section computed tomography-histopathologic comparisons of pulmonary focal interstitial fibrosis, atypical adenomatous hyperplasia, adenocarcinoma in situ, and minimally invasive adenocarcinoma with pure ground-glass opacity","volume":"85","author":"MJ Si","year":"2016","journal-title":"Eur J Radiol"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/j.cllc.2017.06.020","article-title":"Presence of Even a Small Ground-Glass Component in Lung Adenocarcinoma Predicts Better Survival","volume":"19","author":"MF Berry","year":"2018","journal-title":"Clin Lung Cancer"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1378\/chest.13-1094","article-title":"Appropriate sublobar resection choice for ground glass opacity-dominant clinical stage IA lung adenocarcinoma: wedge resection or segmentectomy","volume":"145","author":"Y Tsutani","year":"2014","journal-title":"Chest"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.athoracsur.2017.01.076","article-title":"Importance of Ground Glass Opacity Component in Clinical Stage IA Radiologic Invasive Lung Cancer","volume":"104","author":"A Hattori","year":"2017","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"ref26","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.jtho.2017.02.015","article-title":"Prognostic Impact of the Findings on Thin-Section Computed Tomography in Patients with Subcentimeter Non-Small Cell Lung Cancer","volume":"12","author":"A Hattori","year":"2017","journal-title":"J Thorac Oncol"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/JTO.0b013e31821038ab","article-title":"A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical IA lung cancer (Japan Clinical Oncology Group 0201)","volume":"6","author":"K Suzuki","year":"2011","journal-title":"J Thorac Oncol"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jtcvs.2012.12.047","article-title":"Radiographically determined noninvasive adenocarcinoma of the lung: survival outcomes of Japan Clinical Oncology Group 0201","volume":"146","author":"H Asamura","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.lungcan.2009.03.004","article-title":"Clinicopathological features of small-sized non-small cell lung cancer with mediastinal lymph node metastasis","volume":"66","author":"T Fukui","year":"2009","journal-title":"Lung Cancer"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.athoracsur.2005.07.058","article-title":"Radiologic classification of small adenocarcinoma of the lung: radiologic-pathologic correlation and its prognostic impact","volume":"81","author":"K Suzuki","year":"2006","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"ref31","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0003-4975(03)00835-X","article-title":"A clinicopathological study of resected subcentimeter lung cancers: a favorable prognosis for ground glass opacity lesions","volume":"76","author":"H Asamura","year":"2003","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.lungcan.2015.07.007","article-title":"Association between high-resolution computed tomography findings and the IASLC\/ATS\/ERS classification of small lung adenocarcinomas in Japanese patients","volume":"90","author":"Y Kudo","year":"2015","journal-title":"Lung Cancer"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/RCT.0b013e31815e6291","article-title":"Detection of nodules showing ground\u2010glass opacity in the lungs at low\u2010dose multidetector computed tomography: phantom and clinical study","volume":"33","author":"Y Funama","year":"2009","journal-title":"J Comput Assist Tomogr"},{"issue":"14","key":"ref34","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1088\/0031-9155\/52\/14\/002","article-title":"Application of the noise power spectrum in modern diagnostic MDCT","volume":"52","author":"KL Boedeker","year":"2007","journal-title":"Phys Med Biol"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jtcvs.2018.02.110","article-title":"Ground glass opacities: Imaging, pathology, and gene mutations","volume":"156","author":"F Sun","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/ejcts\/ezr272","article-title":"False-negative rate after positron emission tomography\/computer tomography scan for mediastinal staging in cI stage non-small-cell lung cancer","volume":"42","author":"A G\u00f3mez-Caro","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1159\/000235544","article-title":"Mediastinal lymph node staging in potentially resectable non-small cell lung cancer: a prospective comparison of CT and EUS\/EUS-FNA","volume":"78","author":"I Yasuda","year":"2009","journal-title":"Respiration"},{"issue":"6","key":"ref38","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.jtcvs.2011.08.037","article-title":"A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer","volume":"142","author":"K Yasufuku","year":"2011","journal-title":"J Thorac Cardiovasc Surg"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0212461","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T00:00:00Z","timestamp":1549929600000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0206386","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T17:09:35Z","timestamp":1589044175000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0206386"}},"subtitle":[],"editor":[{"given":"Hyun-Sung","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,10,31]]},"references-count":38,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,10,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0206386","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.pone.0212461","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,31]]}}}